CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study.

Abstract

INTRODUCTION Osteolytic bone destruction is a major clinical problem in multiple myeloma patients. Osteoclasts can differentiate in vitro from bone marrow-resident monocyte progenitors, such as common monocyte progenitors, as well as circulating monocytes. Various types of monocytes, including osteoclast precursors, appear to circulate systemically… (More)
DOI: 10.1111/ijlh.12216

Topics

Cite this paper

@article{Petitprez2015CD14CM, title={CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study.}, author={Vincent Petitprez and Bruno Royer and Judith Desoutter and Eric Guiheneuf and Arnaud Rigoll{\'e} and J. P. Marolleau and Sa{\"{i}d Kamel and Nicolas Guillaume}, journal={International journal of laboratory hematology}, year={2015}, volume={37 1}, pages={29-35} }